Factor V gene mutation is a risk factor for cerebral venous thrombosis

Thrombosis and Haemostasis

Volumn 75, Issue 3, 1996, Pages 393-394

  Martinelli, I ^a   Landi, G ^a   Merati, G ^a   Cella, R ^a   Tosetto, A ^b   Mannucci, P M ^a,c  

^a UNIVERSITY OF MILAN   (Italy)

^b SAN BORTOLO HOSPITAL   (Italy)

^c Hemophilia and Thrombosis Center   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; ANTITHROMBIN; BLOOD CLOTTING FACTOR 5; CONTRACEPTIVE AGENT;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; BLOOD CLOTTING DISORDER; CLINICAL ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; FEMALE; GENE MUTATION; HUMAN; IMMOBILIZATION; INJURY; MALE; OCCLUSIVE CEREBROVASCULAR DISEASE; POINT MUTATION; PREGNANCY; PREVALENCE; PRIORITY JOURNAL; PUERPERIUM; RISK FACTOR; STATISTICAL ANALYSIS; VEIN THROMBOSIS;

EID: 0029875717     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1650284     Document Type: Article

References (14)

1. Kalafatis M, Rand MD, Mann KG. The mechanism of inactivation of human factor V and human factor Va by activated protein C. J Biol Chem 1994; 269: 3869-80.
2. Bertina RM, Koeleman RPC, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, van der Velden PA, Reitsma PH. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64-7.
3. Dahlbäck B. Inherited thrombophilia: resistance to activated protein C as a pathogenic factor of venous thromboembolism. Blood 1995; 85: 607-14.
4. Buonanno FS, Moody DM, Ball MR, Laster DW. Computed cranial tomography findings in cerebral sinovenous occlusion. J Comput Assist Tomogr 1978; 2: 281-90.
5. Frezzato M, Tosetto A, Rodeghiero F. Validation of a questionnaire for the diagnosis of venous thromboembolism. Br J Haematol 1994; 87: 79.
6. de Ronde H, Bertina RM. Laboratory diagnosis of APC-resistance: a critical evaluation of the test and the development of diagnositc criteria. Thromb Haemost 1994; 72: 880-6
7. Mannucci PM, Tripodi A. Laboratory screening of inherited thrombophilic syndroms. Thromb Haemost 1987; 57: 247-51.
8. Feinstein DI. Lupus anticoagulant, anticardiolipin antibodies, fetal loss and systemic lupus erythematosus. Blood 1992; 80: 859-62
9. Enevoldson TP, Ross Russel RW. Cerebral venous thrombosis: new causes for an old syndrome: Quart J Med 1990; 77: 1255-75.
10. Heistinger M, Rumpl E, Illiasch H, Turck H, Kyrle PA, Lechner K, Pabinger I Cerebral sinus thrombosis in a patient with hereditary protein S deficiency: case report and review of the literature. Ann Hematol 1992, 64: 105-9.
11. Ameri A, Bousser MG Cerebral venous thrombosis. In: Cerebral ischemia. treatment and prevention. Barret HJM and Machinski UC, eds. Neurol Clin 1992; 10: 87-111.
12. Bousser MG, Chiras J, Bories J, Castaigne P. Cerebral venous thrombosis. A review of 38 cases. Stroke 1985; 16: 199-213
13. Fairburn B. Intracranial venous thrombosis complicating oral contraception: treatment by anticoagulant drugs. Br Med J 1973; 2: 647.
14. Einhaupl KM, Villringer A, Meister W, Mehraein S, Garner C, Pellkofer M, Haberl RL, Pfister HW, Schmiedek P. Heparin treatment in sinus venous thrombosis. Lancet 1991; 338: 597-600.